Demand for efficient tech transfer, as well as compliant on-time delivery, is rising.
John Thomas
Advertisement
John Thomas is senior director of Drug Product MSAT at Samsung Biologics.
Articles by John Thomas
Advertisement
Latest Updated Articles
Tech Transfer and Regulatory CompliancePublished: November 15th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
